Connect-Home for Alzheimer's Disease and Dementia
(CH-ADRD Trial)

Recruiting in Palo Alto (17 mi)

Overseen byMark Toles, PhD, RN

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of North Carolina, Chapel Hill

No Placebo Group

Trial Summary

What is the purpose of this trial?This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Eligibility Criteria

This trial is for patients with Alzheimer's disease and related dementias who are transitioning from Skilled Nursing Facilities to home or other care settings. Caregivers of these patients are also involved. Specific eligibility details aren't provided, so it's best to contact the study team for more information.

Inclusion Criteria

SNFs must be located within 120 miles of UNC-Chapel Hill

Patients must have a diagnosis of dementia

Patients must have the ability to speak English

+5 more

Exclusion Criteria

I am scheduled to be readmitted to the hospital for a procedure or treatment within 30 days after joining.

Caregivers who are court-appointed guardians

Participant Groups

The Connect-Home ADRD intervention is being tested in this study. It aims to support patients with dementia and their caregivers during the transition from nursing facilities back into home care or other living arrangements.

2Treatment groups

Experimental Treatment

Active Control

Group I: Connect-Home ADRD InterventionExperimental Treatment1 Intervention

The Connect-Home ADRD Intervention will include: 1. Support for SNF staff delivery of transitional care processes including a ADRD transition plan and booklet, caregiver training and engagement, and handoff of care to community providers and Dementia Caregiving Specialist. 2. Support for patients and caregivers provided by the Dementia Caregiving Specialist in three follow-up supportive telephone calls within 30 days of SNF discharge.

Group II: Standard Care - Control GroupActive Control1 Intervention

Patient and caregiver dyad randomized to the control arm will receive usual SNF and post-discharge care.